ArticleCancer2019

A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors.

Stéphanie L Gaillard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.